SWITCH-BLOCKER Trademark

Trademark Overview


On Thursday, November 14, 2024, a trademark application was filed for SWITCH-BLOCKER with the United States Patent and Trademark Office. The USPTO has given the SWITCH-BLOCKER trademark a serial number of 98853592. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 14, 2024. This trademark is owned by Aegea Biotechnologies, Inc.. The SWITCH-BLOCKER trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic reagents and assays for testing of bodily fluids for use in detection of any disease or condition where it is desired to detect specific nucleic acids or derivatives thereof, namely, cancer, infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of gene events, namely, mutations, single nucleotide polymorphisms (SNP's) and other disease biomarkers, translocations, deletions, gene copy number changes, RNA expression levels, and biomarkers specific to disease conditions; drug testing kits comprised of medical diagnostic reagents and assays, test strips, test patches, and test media for various medical purposes

Health assessment services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; and consulting services in the fields of diagnostic medical testing and treatment of diseases

Medical diagnostic apparatus, instruments for testing DNA and RNA and diagnostic testing for the interrogation of DNA and RNA nucleic acids for any disease or condition where it is desired to detect specific nucleic acids or derivative thereof, namely, cancer, an infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs

Medical, scientific and clinical research in the fields of diagnostics, genomics, next generation sequencing (NGS) and therapeutics, molecular diagnostics for the detection of DNA and RNA targets of interest, Sanger sequencing, NGS, capillary electrophoresis, mass-spectral analysis, and microarray analysis

General Information


Serial Number98853592
Word MarkSWITCH-BLOCKER
Filing DateThursday, November 14, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical diagnostic reagents and assays for testing of bodily fluids for use in detection of any disease or condition where it is desired to detect specific nucleic acids or derivatives thereof, namely, cancer, infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of gene events, namely, mutations, single nucleotide polymorphisms (SNP's) and other disease biomarkers, translocations, deletions, gene copy number changes, RNA expression levels, and biomarkers specific to disease conditions; drug testing kits comprised of medical diagnostic reagents and assays, test strips, test patches, and test media for various medical purposes
Goods and ServicesHealth assessment services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; and consulting services in the fields of diagnostic medical testing and treatment of diseases
Goods and ServicesMedical diagnostic apparatus, instruments for testing DNA and RNA and diagnostic testing for the interrogation of DNA and RNA nucleic acids for any disease or condition where it is desired to detect specific nucleic acids or derivative thereof, namely, cancer, an infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs
Goods and ServicesMedical, scientific and clinical research in the fields of diagnostics, genomics, next generation sequencing (NGS) and therapeutics, molecular diagnostics for the detection of DNA and RNA targets of interest, Sanger sequencing, NGS, capillary electrophoresis, mass-spectral analysis, and microarray analysis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAegea Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPoway, CA 92064

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024NEW APPLICATION ENTERED